Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.

The Global Healthy Living Foundation (GHLF) and Guardant Health today announced a new partnership aimed at improving public understanding of colorectal cancer and encouraging timely screening through ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Guardant Health, Inc. is one ...

Penumbra, Inc. today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, ...

Veracyte, Inc. , a leading cancer diagnostics company, announced today that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2026, at 9:45 a.m.

The stock holds the top spot in the Medical-Long Term Care industry, which itself ranks highly, at 17 out of 197 groups ...

The stock market is right at record highs heading into the end of 2025. Nvidia, Google and Apple are all just above buy ...

Military members and veterans can be at a disadvantage in getting screenings that can spot pre-cancerous growths and provide earlier diagnoses.

Investing.com -- The life sciences and diagnostic tools sector is poised for growth in 2026, with several companies well-positioned to capitalize on improving market conditions. According to Bank of ...

Every once in a while, a secular trend is so obvious that everyone can see it, and that is the case with AI. Read more here.

Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.

The fund is an actively-managed exchange-traded fund (“ETF”) that invests primarily in equity securities of small-cap companies listed on a U.S. exchange and selected by Deepwater Asset Management, ...